Literature DB >> 29092855

Risk of uveitis and inflammatory bowel disease in people with psoriatic arthritis: a population-based cohort study.

Rachel Charlton1, Amelia Green1,2, Gavin Shaddick3, Julia Snowball1, Alison Nightingale1, William Tillett1,4, Catherine H Smith5, Neil McHugh1,4.   

Abstract

OBJECTIVES: To determine the risk of uveitis and inflammatory bowel disease (IBD) in patients with psoriatic arthritis (PsA) compared with the general population and patients with psoriasis.
METHODS: A cohort study using data from the UK Clinical Practice Research Datalink between 1998 and 2014. Patients with incident PsA aged 18-89 years were identified and matched to a cohort of patients with psoriasis and a general population cohort. The incidence of uveitis, all IBD, Crohn's disease and ulcerative colitis was calculated for each study cohort and adjusted relative risks (RRadj) were calculated using conditional Poisson regression.
RESULTS: 6783 incident cases of PsA were identified with a median age of 49 years. The risk of uveitis was significantly higher in the PsA cohort than in the general population and psoriasis cohorts (RRadj 3.55, 95% CI 2.21 to 5.70 and RRadj 2.13, 95% CI 1.40 to 3.24, respectively). A significant increase was observed for Crohn's disease (RRadj 2.96, 95% CI 1.46 to 6.00 and RRadj3.60, 95% CI 1.83 to 7.10) but not for ulcerative colitis (RRadj1.30, 95% CI 0.66 to 2.56 and RRadj0.98, 95% CI 0.50 to 1.92).
CONCLUSIONS: In a primary care-based incidence cohort of patients with PsA, there were substantial risks of developing uveitis and/or Crohn's disease, but not ulcerative colitis, when compared with the general population and psoriasis controls. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  arthritis; epidemiology; psoriatic arthritis

Mesh:

Year:  2017        PMID: 29092855     DOI: 10.1136/annrheumdis-2017-212328

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  10 in total

1.  Association of Psoriasis With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.

Authors:  Yun Fu; Cheng-Han Lee; Ching-Chi Chi
Journal:  JAMA Dermatol       Date:  2018-12-01       Impact factor: 10.282

2.  Systematic Review and Meta-Analysis of Inflammatory Bowel Disease Adverse Events with Anti-Interleukin 17A Agents and Tumor Necrosis Factor Inhibitors in Rheumatic Disease and Skin Psoriasis.

Authors:  Steven L Truong; Jasmine Chin; David F L Liew; Syeda Farah Zahir; Elizabeth G Ryan; Diana Rubel; Graham Radford-Smith; Philip C Robinson
Journal:  Rheumatol Ther       Date:  2021-08-26

3.  Association between uveitis and psoriatic disease: a systematic review and Meta-analysis based on the evidence from cohort studies.

Authors:  Chao-Ran Li; Lang Chen; Long-Fei Wang; Bin Yan; You-Ling Liang; Jing Luo
Journal:  Int J Ophthalmol       Date:  2020-04-18       Impact factor: 1.779

4.  Pediatric psoriatic arthritis: a population-based cohort study of risk factors for onset and subsequent risk of inflammatory comorbidities.

Authors:  Timothy G Brandon; Cynthia K Manos; Rui Xiao; Alexis Ogdie; Pamela F Weiss
Journal:  J Psoriasis Psoriatic Arthritis       Date:  2018-09-18

Review 5.  The Conundrum of Psoriatic Arthritis: a Pathogenetic and Clinical Pattern at the Midpoint of Autoinflammation and Autoimmunity.

Authors:  Rossana Scrivo; Salvatore D'Angelo; Antonio Carriero; Chiara Castellani; Fabio Massimo Perrotta; Fabrizio Conti; Matteo Vecellio; Carlo Selmi; Ennio Lubrano
Journal:  Clin Rev Allergy Immunol       Date:  2022-01-18       Impact factor: 8.667

6.  Building a Citizen Pscientist: Advancing Patient-Centered Psoriasis Research by Empowering Patients as Contributors and Analysts.

Authors:  Isabelle M Sanchez; Lindsey Shankle; Marilyn T Wan; Ladan Afifi; Jashin J Wu; Frank Doris; Alisha Bridges; Marc Boas; Brian Lafoy; Sarah Truman; Ana-Maria Orbai; Junko Takeshita; Joel M Gelfand; April W Armstrong; Michael P Siegel; Wilson Liao
Journal:  Dermatol Ther (Heidelb)       Date:  2018-06-06

7.  Term sets: A transparent and reproducible representation of clinical code sets.

Authors:  Richard Williams; Benjamin Brown; Evan Kontopantelis; Tjeerd van Staa; Niels Peek
Journal:  PLoS One       Date:  2019-02-14       Impact factor: 3.240

Review 8.  Psoriatic Arthritis: The Influence of Co-morbidities on Drug Choice.

Authors:  Sneha Patel; Anand Kumthekar
Journal:  Rheumatol Ther       Date:  2021-11-19

9.  Risk of a subsequent diagnosis of inflammatory bowel disease in subjects with ophthalmic disorders associated with inflammatory bowel disease: a retrospective cohort analysis of UK primary care data.

Authors:  Dominic King; Joht Singh Chandan; Tom Thomas; Alastair K Denniston; Tasanee Braithwaite; Krishnarajah Niranthrankumar; Raoul Reulen; Nicola Adderley; Nigel J Trudgill
Journal:  BMJ Open       Date:  2022-05-11       Impact factor: 3.006

10.  Incidence of extra-articular manifestations in ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis: results from a national register-based cohort study.

Authors:  Karin Bengtsson; Helena Forsblad-d'Elia; Anna Deminger; Eva Klingberg; Mats Dehlin; Sofia Exarchou; Ulf Lindström; Johan Askling; Lennart T H Jacobsson
Journal:  Rheumatology (Oxford)       Date:  2021-06-18       Impact factor: 7.580

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.